SynthesisInternational journal of environmental research and public health2022
Prevalence of Multimorbidity in the Middle East: A Systematic Review of Observational Studies.
Synthesis in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Association Between Subjective Symptoms, Psychological Stress and Quality of Life Among Older Japanese Adults.Geriatrics (Basel, Switzerland) · 2026Article
- Prevalence of frailty, multimorbidity, and polypharmacy and their association with health outcomes in hospitalized older adults: a prospective multicenter cohort study.BMC geriatrics · 2026Article
- Cardiometabolic multimorbidity prevalence and its socio-demographic determinants among Iranian adults: insights from the nationwide STEPS 2021.Scientific reports · 2026Article
- Article
- Perioperative outcomes among older surgical patients with multimorbidity: a longitudinal study from Ethiopia.BMC public health · 2025Article
- Demographic, health, and behaviors profile of Saudi Arabia's aging population 2022-2023.Frontiers in aging · 2025Article
- Medication adherence in Jordanian patients with multimorbidity: a cross-sectional mixed-methods study in outpatient clinics.Frontiers in pharmacology · 2025Article
- Multimorbidity and its associated risk factors among adults in northern Sudan: a community-based cross-sectional study.Journal of health, population, and nutrition · 2024Article
- Multimorbidity Patterns in the Urban Population in Poland.Journal of clinical medicine · 2023Article
- Review of multimorbidity in Saudi Arabia: Prevalence, gender differences, and common chronic diseases.Journal of multimorbidity and comorbidityReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere has not been a review that evaluated the prevalence of multimorbidity in the Middle East. This review aims to measure the prevalence, demographic factors, and consequences of multimorbidity in the Middle East region. STUDY
designA quantitative systematic review includes cross-sectional and longitudinal cohort studies.
methodsThe prevalence systematic review approach from the Joanna Briggs Institute was applied. We searched PsychINFO, MEDLINE, EMCARE, CINAHL, Scopus, Science Direct, and the Cochrane Central Register of Controlled Trials. Data were extracted methodically in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) standards. Studies written in English and released between 2012 and March 2022 were included. For the meta-analysis, a random-effects model was applied. PROSPERO registration number: CRD42022335534.
resultsThe final sample consisted of eight cohort and observational studies. The number of participants varied from 354 to 796,427. Multimorbidity was present in all populations with a prevalence of 21.8% (95% confidence interval (CI): 21.7-21.8%).
conclusionMultimorbidity affects a significant section of the world's population. A uniform operationalization of multimorbidity is required in the Middle East in order to enable reliable estimates of illness burden, effective disease management, and resource distribution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.